EU-funded clinical study on the SARS-CoV-2 virus adopted Livebase to build and manage a complex eCRF used by thousands of researchers worldwide.
Read MoreRENOIR is an ongoing clinical trial that aims to evaluate the extent and persistence over time of the humoral and cellular immune response in subjects who received MAbs after SARS-CoV-2 infection.
Read MoreA phase IV randomized, open-label, multicenter study to determine the safety and efficacy of different monoclonal antibodies (MoAbs) to SARS-CoV-2 for the early treatment of COVID-19 in non-hospitalized adults.
Read MoreThe ICONA Foundation manages with Livebase one of the largest Scientific Databases in Europe on HIV
Read MoreGUSTA is a randomized two arms study that compares the switch to DRV/r/MVC with standard HAART with three drugs.
Read MoreTwo related clinical studies aiming to assess the efficacy of switching from EFV/FTC/TDF to BIC/FTC/TAF in virologically suppressed HIV individuals in daily or alternate days regimens.
Read MoreHORFAVID is a cohort, prospective, monocentric study investigating whether fatigue in long-COVID-19 can be explained by hormonal imbalance
Read MoreRASTA study is a 2-arm randomized pilot study exploring the safety and efficacy at 48 weeks of a treatment switch to raltegravir associated with two drugs.
Read MoreThe ESTER study aimed to evaluate the efficacy of switching early to a single-pill regimen from a 5-pill treatment regimen in patients with primary HIV-1 infection.
Read More